化合物EMD534085 TQ0314
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 858668-07-2 | ¥9,620.00 | 询底价 |
5 mg | 858668-07-2 | ¥5,510.00 | 询底价 |
500 μg | 858668-07-2 | ¥686.00 | 询底价 |
1 mg | 858668-07-2 | ¥1,260.00 | 询底价 |
Product Introduction
Bioactivity
英文名: EMD534085
描述: EMD534085 is an effective and selective mitotic kinesin-5 inhibitor (IC50: 8 nM).
细胞实验: Epithelial cell lines HeLa and MCF7 are synchronized in G2-phase using RO-3306. Cells are treated with 10 μM RO-3306 for 16 hrs, and then are ished and released to either warm growth medium or medium supplemented with 500 nM EMD534085 [2].
体外活性: EMD 534085 does not inhibit any other tested kinesins at 1 μM or 10 μM concentration, showing selectively over kinesin-5. EMD 534085 binds to the allosteric pocket of kinesin-5 [1]. EMD534085 induces rapid cell death in HL60 during mitotic arrest. Caspase-8, ?9, ?3, ?7 are activated; Parp1 is cleaved; Mcl1 and XIAP are degraded in EMD534085-treated HL60 cells. EMD534085 treated HL60 cells also show significantly accumulated phospho-histone H3 level starting at 6 hrs post thymidine release [2].
体内活性: In a low dose PK of EMD 534085 in mice, the clearance is 1.8 L/h/kg on average, the volume of distribution is 7.4 L/kg and the half-life around 2.5 h. The bioavailability in high dose experiments (>10 mg/kg) is always above 50% in mice. Intraperitoneal administration of EMD 534085 enables significant systemic exposure in mice leading to a significant tumor growth reduction without toxic side effects [1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 25 mg/mL (52.46 mM)
关键字: EMD-534085 | EMD 534085 | EMD534085
相关产品: Ispinesib | Monastrol | BOS-172722 | Empesertib | SB-743921 hydrochloride | TC-Mps1-12 | SR31527 | Dimethylenastron | Litronesib | Mps1-IN-2
化合物EMD534085 TQ0314信息由TargetMol中国为您提供,如您想了解更多关于化合物EMD534085 TQ0314报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途